A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/1999
11/02/1999	US5976541 Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope
11/02/1999	US5976539 Compositions and methods for use of IL-12 as an adjuvant
11/02/1999	US5976538 Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
11/02/1999	US5976537 A previously unknown disease of pigs, prrs was recognized for the first time in the united states in north carolina in 1987. from there, it quickly spread throughout all of the major swine producing areas of north america.
11/02/1999	US5976536 Neisseria mutants, lipooligosaccharides and immunogenic compositions
11/02/1999	US5976534 Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin
11/02/1999	US5976533 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor
11/02/1999	US5976519 Obtained from an egg of a domestic fowl immunized using, as an antigen, whole human hair, e.g., normal human hair or human hair damaged by permanent waving, dyeing or bleaching, or hair particles
11/02/1999	US5976492 Radioactive phosphorus labeled proteins for targeted radiotherapy
11/02/1999	CA2144055C Cloning and sequencing of allergens of dermatophagoides (house dust mite)
11/02/1999	CA2053911C Recombinant antibody-toxin fusion protein
10/1999
10/30/1999	CA2270754A1 Selection process for bacterial strain
10/28/1999	WO1999054738A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/28/1999	WO1999054735A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	WO1999054706A2 Method of treating interstitial cystitis with recombinant hb-egf
10/28/1999	WO1999054485A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999	WO1999054479A2 INHIBITION OF ALKYL HYDROPEROXIDE REDUCTASE, SUBUNIT C (AhpC) TO IMPART SUSCEPTIBILITY TO ANTIMICROBIAL REACTIVE NITROGEN INTERMEDIATES
10/28/1999	WO1999054469A1 B-cell growth factor related protein
10/28/1999	WO1999054468A1 Soluble protein ztmpo-1
10/28/1999	WO1999054466A2 Colon cancer-associated antigens and their diagnostic and therapeutic uses
10/28/1999	WO1999054464A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY
10/28/1999	WO1999054457A1 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates
10/28/1999	WO1999054447A2 Human nucleic acid sequences of bladder tumour tissue
10/28/1999	WO1999054440A1 CD19xCD3 SPECIFIC POLYPEPTIDES AND USES THEREOF
10/28/1999	WO1999054354A1 Sp22, a fertility-associated protein from sperm and a method for evaluating and affecting male fertility using it
10/28/1999	WO1999054349A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	WO1999054342A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
10/28/1999	WO1999053960A2 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999	WO1999053958A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999	WO1999053953A2 Methods and products related to metabolic interactions in disease
10/28/1999	WO1999053952A1 Method for producing a specific antiserum against the universal tumorous antigen and method for diagnosing malignant tumours using said antiserum
10/28/1999	WO1999053950A2 Live vaccines and methods of treatment therewith
10/28/1999	WO1999053949A2 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	WO1999053948A1 Chlamydia proteins and their uses
10/28/1999	WO1999053947A1 Th2-MIGRATION PROMOTERS CONTAINING W/O EMULSIONS
10/28/1999	WO1999053946A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999	WO1999053945A1 Neuron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration
10/28/1999	WO1999053940A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR
10/28/1999	WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999	WO1999053931A1 Tumor cells with increased immunogenicity and uses thereof
10/28/1999	WO1999053912A1 Topical immunostimulation to induce langerhans cell migration
10/28/1999	WO1999053900A1 Drug delivery of proteins from polymeric blends
10/28/1999	WO1999053757A1 Autoantigenic fragments, methods and assays
10/28/1999	WO1999041404A3 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
10/28/1999	WO1999040946A3 Methods and compositions for modulating leptin activity
10/28/1999	WO1999040937A3 Vaccines comprising interleukin-12 and respiratory syncytial viral antigens
10/28/1999	WO1999040936A3 Pneumococcal and meningococcal vaccines formulated with interleukin-12
10/28/1999	WO1999029341A3 Methods for enhancement of protective immume responses employing leishmania polypeptides
10/28/1999	WO1999027080A3 Human protein kinase and kinase inhibitors
10/28/1999	WO1999024463A3 Signal peptide-containing proteins
10/28/1999	WO1999005272A9 Use of transcription factor brn-3a
10/28/1999	WO1998040099A9 Leptospira pathogens
10/28/1999	DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
10/28/1999	CA2658218A1 Improved immunodiagnostic assays using reducing agents
10/28/1999	CA2329495A1 Autoantigenic fragments, methods and assays
10/28/1999	CA2329302A1 Modifications of antigens by the introduction of aldehyde groups and their use in enhancing the immune response
10/28/1999	CA2328774A1 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf)
10/28/1999	CA2328399A1 Pneumococcal surface protein c(pspc), epitopic regions and strain selection thereof, and uses therefor
10/28/1999	CA2328081A1 Enhancement of antibody-cytokine fusion protein mediated immune responses by co-administration with prostaglandin inhibitor
10/28/1999	CA2326685A1 Enhancing immune responses to genetic immunization by using a chemokine
10/28/1999	CA2326406A1 Combination of antigen pulsed apcs and interleukin 12 for tumor and viral therapy
10/28/1999	CA2326002A1 Chlamydia proteins and their uses
10/28/1999	CA2325864A1 Mutated peptide compounds, derived from hsp70, useful in cancer immunotherapy
10/28/1999	CA2325848A1 B-cell growth factor related protein
10/28/1999	CA2325822A1 Soluble protein ztmpo-1
10/28/1999	CA2325573A1 A method for inhibiting tumor invasion or spreading in a subject
10/28/1999	CA2325391A1 Dermatophagoides nucleic acid molecules, proteins and uses thereof
10/28/1999	CA2324995A1 Methods and products related to metabolic interactions in disease
10/28/1999	CA2324975A1 Isolated nucleic acid molecule encoding cancer associated antigens, the antigens per se, and uses thereof
10/27/1999	EP0952218A2 Single chain, multiple antigen-binding molecule, its preparation and use
10/27/1999	EP0952214A1 Aviadenovirus
10/27/1999	EP0951917A2 Particle delivery of particularly a powdered therapeutical agent
10/27/1999	EP0951559A1 Recombinant pox virus for immunization against tumor-associated antigens
10/27/1999	EP0951556A2 Disease associated protein tyrosine phosphatases
10/27/1999	EP0951555A2 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
10/27/1999	EP0951554A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine
10/27/1999	EP0951552A2 Dna and specific proteins or peptides of the neisseria meningitidis species bacteria, method for obtaining them and their biological applications
10/27/1999	EP0951551A2 Ligand for receptor activator of nf-kappa b, ligand is member of tnf superfamily
10/27/1999	EP0951546A2 Compositions and methods of use for osteoclast inhibitory factors
10/27/1999	EP0951545A2 Human gtp-binding proteins
10/27/1999	EP0951481A1 Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis
10/27/1999	EP0951480A1 Method and novel compounds for use therein
10/27/1999	EP0951477A1 Lymphocyte stimulating factor from trypanosoma
10/27/1999	EP0951475A1 Metastatic colorectal cancer vaccine
10/27/1999	EP0951469A1 Novel compounds
10/27/1999	EP0951299A1 Method of producing active immunity with vaccine conjugate
10/27/1999	EP0951296A1 NOVEL FtsL
10/27/1999	EP0951295A1 Methods and compositions useful for inhibition of angiogenesis
10/27/1999	EP0951292A1 Methods for treating an ischemic disorder and improving stroke outcome
10/27/1999	EP0951289A1 $i(MYCOBACTERIUM VACCAE) FOR DOWN-REGULATION OF THE TH2 ACTIVITY OF THE IMMUNE SYSTEM
10/27/1999	EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999	CN1233288A GnRH-leukotoxin chimeras
10/27/1999	CN1233258A Method for producing an IgM preparation for intravenous administration
10/27/1999	CN1233189A Treatment of asthma with TNFR-Ig
10/27/1999	CN1233187A HIVp-17 peptide fragment, compositions containing and methods for producing and using same
10/27/1999	CN1233185A Nucleosome-based anti-tumor compositions
10/27/1999	CN1232704A Culture process of high-yield weak-toxicity distemper cell strain
10/26/1999	US5973132 Expression of dna coding for house dust mite allergens.
10/26/1999	US5973121 The ingestion of peanuts is a common cause of food hypersensitivity reactions.
10/26/1999	US5973116 Compounds for targeting

1 ... 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 ... 1823